Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05024344 · ClinicalTrials.gov registry record · NA
ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy
A NA study of Nephrolithotomy, Percutaneous, sponsored by University of Tennessee Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 1
- Study location
NCT05024344 is a NA study of Nephrolithotomy, Percutaneous that is actively recruiting participants, run by University of Tennessee Medical Center. The registered enrollment target is 128 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05024344, a NA study of Nephrolithotomy, Percutaneous, is actively recruiting participants, sponsored by University of Tennessee Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. \- Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption with the usage of an ESP block vs. saline control. 2. \- Determine if there is a significant effect on reported pain levels with the use of an ESP block vs. saline control in post percutaneous nephrolithotomies.
Conditions Studied
Interventions
- DRUG Dexamethasone
- PROCEDURE Erector Spinae Plane Block
- DRUG Ropivacaine 0.5% Injectable Solution
Study Locations (1)
Tennessee
- University of Tennessee Medical Center - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2021-08-09 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05024344
The ClinicalTrials.gov registry entry for NCT05024344 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee Medical Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nephrolithotomy, Percutaneous appearing as the primary indexed condition, and to 3 interventions - of which Dexamethasone is the first listed.
NCT05024344 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05024344 about?
NCT05024344 is a clinical study titled "ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy". The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. \- Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption ...
What is the current status of trial NCT05024344?
This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2021-08-09. Estimated completion is 2026-06-30.
What conditions does trial NCT05024344 study?
This clinical trial studies the following conditions: Nephrolithotomy, Percutaneous.
What interventions are being tested in trial NCT05024344?
The interventions under investigation include: Dexamethasone (DRUG), Erector Spinae Plane Block (PROCEDURE), Ropivacaine 0.5% Injectable Solution (DRUG).
Who is sponsoring clinical trial NCT05024344?
This trial is sponsored by University of Tennessee Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05024344 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.